|
Diabetes
References
Acarbose improves diabetes that is poorly controlled by other oral drugs. Medical Sciences Bulletin. September 1998; vol. 252.
American Diabetes Association URL: http://www.diabetes.org/home.jsp. Accessed May 2005, June 2006, April 2007, and March 2008.
American Diabetes Association. Economic Costs of Diabetes in the US in 2007. Diabetes Care 2008; 31:1-20.
American Diabetes Association. Clinical Practice Recommendations for Patients with Diabetes Mellitus 2008. Diabetes Care 2008 31:S3-108.
Aminoguanidine.Drug evaluation monograph. Micromedex, Inc. February 1998.
Cameron NE, Cotter MA. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition. Metabolism. 1996;45(9):1147-1152.
CDC Diabetes Public Health Resource URL: http://www.cdc.gov/diabetes. Accessed August 2003, June 2006, April 2007, and March 2008.
Diabetes Statistics. National Institute of Diabetes and Digestive and Kidney Diseases. National Institutes of Health. US Public Health Service. URL: http://diabetes.niddk.nih.gov/dm/pubs/statistics. Accessed March 2008.
Ellis S. Diabetes update. The Express 1997;14(4):1-5.
Friedman EA, Distant DA, Fleishhacker JF, et al. Aminoguanidine prolongs survival in azotemic-induced diabetic rats. American Journal of Kidney Disease. 1997;30(2):253-259.
Guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance. Diabetes Care. 1997; vol. 20.
Humalog information for the patient. Available at: http://www.drugdigest.org/DD/DVH/Uses/0,3915,346|Humalog,00.html. Accessed May 2005, June 2006, April 2007, and March 2008.
Lap-Band Procedure. Laparoscopic Obesity Surgery with the LAP-BAND? Adjustable Gastric Banding System. URL: http://www.obesitylapbandsurgery.com/tecmain.html. Accessed March 2008.
Makita Z, Yanagisawa K, Kuwajima S, et al. Advanced glycation end-products and diabetic nephropathy. Journal of Diabetes Complications. 1995;9(4):265-268.
Mayo Clinic.com. Diabetes: Self care. Available at: http://www.mayoclinic.com/health/self-care-book/GA00023. Accessed April 2007 and March 2008.
Mayo Clinic.com. Polycystic Ovary Syndrome. Available at: http://www.mayoclinic.com/invoke.cfm?id=DS00423. Accessed August 2003, June 2006, April 2007, and March 2008.
National Diabetes Education Program. Foot Care Kit for Diabetes: Help Prevent Amputations. Available at http://ndep.nih.gov/diabetes/pubs/Feet_Kit_Eng.pdf . Accessed Feb 2001, June 2006, April 2007, and March 2008.
New and emerging therapies in the treatment of type 2 diabetes. The American Journal of Managed Care: Special Report. 1997;3 (supplement) S6-S39.
O'Connor PJ, and Rush WA. The cost to health plans of poor glycemic control. Diabetes Care. 1997;20(12):1847-1853.
Official Byetta webpage. http://www.byetta.com/index.jsp?reqNavId=0. Accessed June 2005, June 2006, April 2007, and March 2008.
Official Symlin webpage. http://www.symlin.com. Accessed June 2005, June 2006, April 2007, and March 2008.
Ponce J, Haynes B, Paynter S, et. al. Effect of Lap-Band-Induced Weight Loss on Type 2 Diabetes Mellitus and Hypertension. Obesity Surgery. 2004;14:1335-1342.
Reddy GK; Stehno-Bittel L; Hamade S; et al. The biomechanical integrity of bone in experimental diabetes. Diabetes Res Clin Pract 2001 Oct;54(1): p. 1-8
Report from the American Diabetes Association. Economic consequences of diabetes mellitus in the US in 1997. Diabetes Care. 1998; vol. 21(2).
Skamarauskas JT, McKay AG, Hunt JV. Aminoguanidine and its pro-oxidant effects on an experimental model of protein glycation. Free Radical Biologic Medicine. 1996;21(6):801-812.
Transdermal Insulin Delivery. Diabetes Mall. URL: http://www.diabetesnet.com/diabetes_treatments/insulin_skin.php. Accessed March 2008.
The American Association of Clinical Endocrinologists and the American College of Endocrinology. AACE guidelines for the management of diabetes mellitus. 2007; Available at:http://www.aace.com/pub/guidelines/. Accessed April 2007 and March 2008.
The Diabetes Control and Complications Trial and Research Group. The effects of intensive treatment of diabetics on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329(14):977-986
Turner R, Cull C, Holman R. United Kingdom prospective diabetes study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Annals of Internal Medicine. 1996;124(1):136-145.
US Food and Drug Administration approves Prandin, new oral treatment for type 2 diabetes; press release. Princeton, New Jersey: Novo Nordisk; June 8, 1998.
U.S. Food and Drug Administration. FDA Issues Safety Alert on Avandia. URL: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01636.html. Accessed March 28, 2008.
Zimmerman GA, Meistrell M 3rd, Bloom O, and others. Neurotoxicity of advanced glycation of end-products during focal stroke and neuroprotective effects of aminoguanidine. Proceedings of the National Academy of Science.1995; 92(9):3744-3748.
|
References
